LifeStance Health Group, Inc.
LifeStance Health Group, Inc. (LFST) Revenue
Annual & quarterly revenue history · segment & region breakdown
LFST · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsLifeStance Health Group, Inc. trailing twelve-month (TTM) revenue is $1.49B, an increase of 13.85% year-over-year from $1.42B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.42B | +$0.17B | +13.85% |
| 2024-12-31 | $1.25B | +$0.20B | +18.50% |
| 2023-12-31 | $1.06B | +$0.20B | +22.82% |
| 2022-12-31 | $0.86B | +$0.19B | +28.77% |
| 2021-12-31 | $0.67B | +$0.29B | +76.96% |
| 2020-12-31 | $0.38B | +$0.16B | +77.50% |
| 2019-12-31 | $0.21B | — | — |
Compare revenue vs peers
Medical - Care FacilitiesCompare LFST revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income LifeStance Health Group, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
LifeStance Health Group, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from LifeStance Health Group, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LFST revenue · 4 questionsLFST's trailing twelve-month (TTM) revenue is $1.49B. That is an increase of 13.85% year-over-year from $1.42B in FY2025.
▸ Source: FMP · LifeStance Health Group, Inc. SEC filings · GAAP · LifeStance Health Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026